Greater than 96.0% as determined by RP-HPLC.
The purity of the Glucagon is confirmed to be greater than 96.0% through RP-HPLC analysis.
Glucagon was first identified in 1923 by Kimball and Murlin, who discovered a substance in pancreatic extracts that caused hyperglycemia, which they named glucagon . Over the past century, the importance of glucagon in human physiology and disease has been extensively studied, leading to the development of drugs targeting the glucagon receptor family to treat metabolic diseases .
Glucagon is a 29-amino acid polypeptide with a molecular mass of 3485 daltons . Its primary structure in humans is:
NH2 - His - Ser - Gln - Gly - Thr - Phe - Thr - Ser - Asp - Tyr - Ser - Lys - Tyr - Leu - Asp - Ser - Arg - Arg - Ala - Gln - Asp - Phe - Val - Gln - Trp - Leu - Met - Asn - Thr - COOH
The hormone is synthesized and secreted from alpha cells (α-cells) of the islets of Langerhans, located in the endocrine portion of the pancreas . Glucagon is produced from the preproglucagon gene (Gcg). Preproglucagon first has its signal peptide removed by signal peptidase, forming the 160-amino acid protein proglucagon. Proglucagon is then cleaved by proprotein convertase 2 to glucagon in pancreatic islet α cells .
Glucagon’s primary function is to raise blood glucose levels, preventing hypoglycemia . It achieves this by:
Glucagon works in opposition to insulin, which lowers blood glucose levels. Together, glucagon and insulin form a feedback system that maintains stable blood glucose levels .